contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


bavarian-nordic-provides-clarification-on-the-hera-framework-agreement-and-the-public-preparedness-business

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Bavarian Nordic är verksamt inom biokemi. Idag är bolaget specialiserat inom utveckling, produktion och distribution av vaccin mot infektionssjukdomar i samband med cancerbehandling. Utöver huvudverksamheten framställs även vacciner mot allvarliga sjukdomar som ebola och livmoderhalscancer. Störst verksamhet återfinns inom Europa och Nordamerika, med huvudkontoret beläget i Kvistgaard, Danmark.

Bavarian Nordic

COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and Response Authority (HERA) framework agreement...

COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and Response Authority (HERA) framework agreement, announced yesterday, and the Public Preparedness business. The initial order for 750,000 doses of MVA-BN smallpox/mpox vaccine that was announced yesterday will be delivered in 2026 and is the result of a new joint procurement contract by the European Commission, through the HERA. This represents the second order received for next year, following the earlier award of a contract option from Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) announced in May. The company anticipates additional orders for MVA-BN over the course of the next year, but the BARDA and HERA orders are an encouraging start to building a base preparedness business of DKK 1.5-2 billion for 2026, consistent with previous guidance. The award of the HERA agreement does not affect the 2025 guidance. About Bavarian Nordic Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit <a href="https://www.globenewswire.com/Tracker?data=BWOMics6oAy5bS4BO3md_04paTdT4T1gAlY6RwSe1aj344ZOrcrOETuSDlmSMo0ul1eDbyN2Ukj-Ki1w6oE61xG1b0btZZliwsQFmiaXnsGtO9s5yCDu1czSiaUV_oj4">www.bavarian-nordic.com</a>. Contact investors: Europe: Disa Tuominen, IR Manager, <a href="https://www.globenewswire.com/Tracker?data=X5dJOTrXWwMhF3_eglX3ZIIkWSaaljmq41wxGfydz5ihWuhcTNQfI0IZVNFIvXaJNcJdeRaQobQESh7KR2W2Vgv8IPiNjsQSseMHbktw2Q-6ziZFP8ovCWbY-ru7Sid0">detu@bavarian-nordic.com</a> US: Graham Morrell, Gilmartin Group, <a href="https://www.globenewswire.com/Tracker?data=SydVqYhHAXqdlS_zEXXbShzOcgUtuyEXNFZ_Wu7Ei5rMni94QjEKPlvEUphCpgYJd8szZFonALQw8gU9vjpVkNtF8T5Yib9dUSCo3beE8_c=">graham@gilmartinir.com</a>, Tel: +1 781 686 9600 Contact media: Nicole Seroff, Vice President Corporate Communications, <a href="https://www.globenewswire.com/Tracker?data=Su1c1hkAYkfYuQDDxEs8lnaueXd7i-XK5Q06Nuw4SD9KEuKqZGIHH3PpPyY1pPsJfp9rhUDjDOgEQpE1-s2YqFniYb3zQyXhCWOAX7kjdeopSVS8tgVpz2O7wO7-OKfW">nise@bavarian-nordic.com</a>, Tel: +45 53 88 06 03 Attachment<ul> <li> <a href="https://ml-eu.globenewswire.com/Resource/Download/ac727f46-9c71-4402-9db4-3c9744fbf65f">Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business</a> </li> </ul><img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTEzNjM3MCM0MDIyNTc5ODIjMjAwMDUwMg==" alt=""> <img src="https://ml-eu.globenewswire.com/media/ZGVhMDNiYzktYzUwYi00YTMxLThhYWYtYjZjOTZlYjMwMTA3LTEwMTIwNzUtMjAyNS0xMS0wMS1lbg==/tiny/Bavarian-Nordic-A-S.png" alt="">

Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business